Stiffness is more than just duration and severity: A qualitative exploration in people with rheumatoid arthritis

Rheumatology (United Kingdom)

Volumn 54, Issue 4, 2014, Pages 615-622

  Halls, Serena ^a,c   Dures, Emma ^a   Kirwan, John ^b   Pollock, Jon ^a   Baker, Gill ^c   Edmunds, Avis ^c   Hewlett, Sarah ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Patient experience; Qualitative; Rheumatoid arthritis; Stiffness

Indexed keywords

GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; JOINT STIFFNESS; LEISURE; MALE; MIDDLE AGED; MUSCLE RIGIDITY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; RIGIDITY; SEMI STRUCTURED INTERVIEW; THEMATIC ANALYSIS;

EID: 84926467248     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu379     Document Type: Article

References (43)

1. Arthur V, Hill J. The musculoskeletal system and rheumatic diseases. In: Hill A, ed. Rheumatology Nursing: A Creative Approach. Chichester: John Wiley & Sons, 2006:25-92.
2. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
3. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
4. Kirwan JR, Chaput de Saintonge DM, Joyce CRB, Currey HLF. Clinical judgment in rheumatoid arthritis. III. British rheumatologists' judgments of 'change in response to therapy'. Ann Rheum Dis 1984;43:686-94.
5. Soubrier M, Zerkak D, Gossec L et al. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice? J Rheumatol 2006;33:1243-6.
6. Kalyoncu U, Dougados M, Daures JP, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2009;68:183-90.
7. Buttgereit F, Doering G, Schaeffler A et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 2008;371:205-14.
8. Clarke LL, Jessop DS, Hunt LP et al. Alleviation of morning joint stiffness by low dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. Int J Clin Rheumatol 2011;6:241-9.
9. Perry MG, Kirwan JR, Jessop DS, Hunt LP. Overnight variation in cortisol, interleukin 6, tumour necrosis factor a and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 2009;68:63-8.
10. Straub RH, Cutolo M. Circadian rhythms in rheumatoid arthritis. Implications for pathophysiology and therapeutic management. Arthritis Rheum 2007;56: 399-408.
11. Scott JT. Morning stiffness in rheumatoid arthritis. Ann Rheum Dis 1960;19:361-8.
12. Vliet Vlieland TP, Zwinderman AH, Breedveld FC, Hazes JM. Measurement of morning stiffness in rheumatoid arthritis clinical trials. J Clin Epidemiol 1997;50:757-63.
13. da Silva J, Phillips S, Buttgereit F. Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis. Scand J Rheumatol. 2011;40:6-11.
14. Westhoff G, Buttgereit F, Gromnica-Ihl E, Zink A. Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. J Rheumatol 2008; 47:980-4.
15. Phillips S, Dow L. Impact of impaired morning function on quality of life in rheumatoid arthritis: results of an exploratory patient survey. Int J Clin Rheumatol 2012;7: 597-606.
16. Hewlett S, Sanderson T, May J et al. 'I'm hurting and I want to kill myself': rheumatoid arthritis flares is more than a high joint count-an international patient perspective on flare where medical help is sought. Rheumatology 2012; 51:69-76.
17. Bartlett SJ, Hewlett S, Bingham CO et al. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis 2012;71: 1855-60.
18. van Tuyl LHD, Hewlett S, Sadlonova M et al. The patient perspective on remission in rheumatoid arthritis: 'you've got limits but you're back to being you again'. Ann Rheum Dis 2014 Feb 12. doi: 10.1136/annrheumdis-2013-204798. [Epub ahead of print].
19. Rhind VM, Unsworth A, Haslock I. Assessment of stiffness in rheumatology: the use of rating scales. Rheumatology 1987;26:126-30.
20. Lineker SA, Badley E, Charles C, Hart L, Streiner D. Defining morning stiffness in rheumatoid arthritis. J Rheumatol 1999;26:1052-7.
21. Smolen JS, LandewéR, Breedveld FC et al. EULAR recommendation for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69: 964-75.
22. Patrick DL, Burke LB, Powers JH et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10:S125-37.
23. Ritchie J, Lewis J. Qualitative Research Practice. A Guide for Social Science Students and Researchers. London, UK: Sage, 2003.
24. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23: 137-45.
25. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
26. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101.
27. QSR International. NVivo qualitative data analysis software. Version 10. Doncaster, VC, Australia: QSR International, 2012.
28. Hewlett S, de Wit M, Richards P et al. Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Care Res 2006;55:676-80.
29. Khan NA, Yazici Y, Calvo-Alen J et al. Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activity. J Rheumatol 2009;36: 2435-42.
30. van Tuyl LHD, Lems WF, Boers M. Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review. BMC Musculoskelet Disord 2014;15:28.
31. Hazes JM, Hayton R, Silman AJ. A re-evaluation of the symptom morning stiffness. J Rheumatol 1993;20: 1138-42.
32. Sanderson TC, Hewlett SE, Flurey C et al. The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic disease. J Rheumatol 2011;38: 191-4.
33. Patrick DL, Burke L, Gwaltney CJ et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health 2011;14: 967-77.
34. Patrick DL, Burke L, Gwaltney CJ et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2-assessing respondent understanding. Value Health 2011;14:978-88.
35. Guest G, Bunce A, Johnson L. How many interviews are enough? Field Methods 2006;18:59-82.
36. Mays N, Pope C. Rigour and qualitative research. BMJ 1995;311:109-12.
37. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for Industry: Patient-Reported Outcome Measures. Use in Medical Product Development to Support Labeling Claims, 2009. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf (21 August 2014, date last accessed).
38. Kirwan J, Minnock P, Adebajo A et al. Patient perspective: fatigue as a recommended patient centred outcome measure in rheumatoid arthritis. J Rheumatol 2007;34: 1174-7.
39. Nicklin J, Cramp F, Kirwan J, Urban M, Hewlett S. Collaboration with patients in the design of patient reported outcome measures: Capturing the experience of fatigue in RA. Arthritis Care Res 2010;62: 1552-8.
40. Nicklin J, Cramp F, Kirwan J, Urban M, Hewlett S. Measuring fatigue in RA: a cross-sectional study to evaluate the BRAF Multi-Dimensional questionnaire, visual analogue and numerical rating scales. Arthritis Care Res 2010;62:1559-68.
41. Dures E, Hewlett S, Cramp F et al. Reliability and sensitivity to change of the Bristol Rheumatoid Arthritis Fatigue scales. Rheumatology 2013;52: 1832-9.
42. Felson D, Anderson JJ, Boers M et al. The ACR preliminary core set of disease activity measures for RA clinical trials. Arthritis Rheum 1993;36:729-40.
43. Bingham C, Alten R, Bartlett S et al. Identifying preliminary domains to detect and measure RA flares: report of the OMERACT 10 RA Flare Workshop. J Rheumatol 2011;38: 1751-8.